全文获取类型
收费全文 | 80948篇 |
免费 | 17398篇 |
国内免费 | 2031篇 |
专业分类
耳鼻咽喉 | 945篇 |
儿科学 | 3349篇 |
妇产科学 | 2344篇 |
基础医学 | 5547篇 |
口腔科学 | 3196篇 |
临床医学 | 10953篇 |
内科学 | 20161篇 |
皮肤病学 | 1318篇 |
神经病学 | 5749篇 |
特种医学 | 2550篇 |
外国民族医学 | 3篇 |
外科学 | 11317篇 |
综合类 | 3742篇 |
现状与发展 | 12篇 |
一般理论 | 19篇 |
预防医学 | 11205篇 |
眼科学 | 2640篇 |
药学 | 3640篇 |
4篇 | |
中国医学 | 564篇 |
肿瘤学 | 11119篇 |
出版年
2024年 | 236篇 |
2023年 | 2324篇 |
2022年 | 2007篇 |
2021年 | 2262篇 |
2020年 | 2994篇 |
2019年 | 1837篇 |
2018年 | 4715篇 |
2017年 | 3644篇 |
2016年 | 3282篇 |
2015年 | 3298篇 |
2014年 | 3090篇 |
2013年 | 4123篇 |
2012年 | 4257篇 |
2011年 | 5465篇 |
2010年 | 3559篇 |
2009年 | 3885篇 |
2008年 | 4803篇 |
2007年 | 4472篇 |
2006年 | 4337篇 |
2005年 | 4195篇 |
2004年 | 5135篇 |
2003年 | 4836篇 |
2002年 | 3590篇 |
2001年 | 3054篇 |
2000年 | 1384篇 |
1999年 | 1502篇 |
1998年 | 1335篇 |
1997年 | 1194篇 |
1996年 | 1638篇 |
1995年 | 859篇 |
1994年 | 788篇 |
1993年 | 556篇 |
1992年 | 525篇 |
1991年 | 491篇 |
1990年 | 404篇 |
1989年 | 389篇 |
1988年 | 334篇 |
1987年 | 329篇 |
1986年 | 293篇 |
1985年 | 254篇 |
1984年 | 196篇 |
1983年 | 170篇 |
1982年 | 145篇 |
1981年 | 129篇 |
1975年 | 144篇 |
1974年 | 154篇 |
1973年 | 147篇 |
1972年 | 129篇 |
1971年 | 135篇 |
1969年 | 129篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
María Cabrerizo Gloria Trallero María José Pena Amaia Cilla Gregoria Megias Carmen Mu?oz-Almagro Eva Del Amo Diana Roda Ana Isabel Mensalvas Antonio Moreno-Docón Juan García-Costa Nuria Rabella Manuel Ome?aca María Pilar Romero Sara Sanbonmatsu-Gámez Mercedes Pérez-Ruiz María José Santos-Mu?oz Cristina Calvo And the study group of “Enterovirus parechovirus infections in children under ?years-old Spain” PI- 《European journal of pediatrics》2015,174(11):1511-1516
5.
GIUSEPPE BORIANI MAURO BIFFI MAURIZIO RUSSO† MAURIZIO LUNATI‡ GIANLUCA BOTTO¶ ALESSANDRO PROCLEMER§ GIUSEPPE VERGARA WERNER RAHUE†† CRISTIAN MARTIGNANI RENATO RICCI† MASSIMO SANTINI† On Behalf of the SEARCH MI Registry Italian Investigators 《Pacing and clinical electrophysiology : PACE》2006,29(S2):S29-S34
Background: Large randomized trials show that in appropriately selected patients with left ventricular dysfunction, implantable cardioverter-defibrillators (ICDs) can improve overall survival at 2–5 years. Since direct implementation of the criteria used in the MADIT II and SCD-HeFT will lead to a marked rise in ICD implants, there is a growing fear that increased use of ICDs may cause a dramatic burden to health care systems. The ICD has traditionally been seen as an expensive form of treatment, which is difficult to accept at the first look. This is mainly due to the nonlinear character of the ICD investment, characterized by high initial expenditure, followed by a deferred pay-off in terms of clinical benefits. Cost-effectiveness analysis may help provide a different perspective on the problem of ICD cost, as may estimation of the daily cost of ICD treatment, assuming a time horizon of 5–7 years—a particularly interesting subject for further registry studies.
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
6.
7.
8.
9.
Lisa A. Lang DDS MS David C. Holmes DDS MS Craig Passon DDS MS Robert M. Trombly DDS JD Jeffrey D. Astroth DDS MSPH Arnold F. Tavel DMD 《Journal of prosthodontics》2003,12(3):206-210
Using complete denture treatment as an introduction to clinical patient care for dental students, the purposes of the Complete Denture Prosthodontics Transition Clinic at the University of Colorado School of Dentistry are to reduce the time lapse between the preclinical complete denture prosthodontics course and the first denture patient experience, and to encourage development of student self-confidence and skills. In the 2002 spring semester, faculty at the University of Colorado School of Dentistry initiated the Complete Denture Prosthodontics Transition Clinic for DS-II (second-year) dental students, as an introduction to clinical patient care. Each patient was assigned to a team of two dental students. Three Division of Prosthodontics faculty members staffed each clinic session, providing a student-to-faculty ratio of approximately 6.6:1 and a patient-to-faculty ratio of approximately 3.3:1. All DS-II students in the Class of 2004 delivered their first complete dentures no later than 8 months (average, 184 days) after the last day of the preclinical complete denture prosthodontics course. The time from the diagnostic appointment through the denture placement appointment averaged 39 days for patients treated in this program, compared with an average of 98 days or more for previous classes. The program was successful in achieving the goal of reducing the time lapse between the preclinical complete denture prosthodontics course and the first denture patient experience. 相似文献
10.
Robin L. Bissinger MSN RNC NNP Cheryl A. Carlson MS RNC NNP 《Newborn and Infant Nursing Reviews》2006,6(2):87
Surfactant, a complex substance containing specific proteins and phospholipids, is essential for gas exchange in the lungs. Research shows that surfactant not only lowers surface tension, but also plays a role in host defense. Surfactant replacement therapy is a cornerstone in the treatment of respiratory distress syndrome in premature infants. New information on endogenous surfactant composition including surfactant apoproteins has led to advances in the surfactant replacement products currently available. Because of the success of surfactant deficiency treatment in neonates, surfactant replacement therapy has been studied in both the pediatric and adult population for the treatment of other respiratory disorders. This article describes the composition, metabolism, and function of endogenous surfactant and other uses of surfactant replacement therapies in neonates. 相似文献